Biggest News Aggregation in the World
📰 Cel Sci News

Page 2 - Cel Sci News Today

Fast, Ad-Free News Updates

Stay updated with breaking news from Cel Sci. Real-time updates on events, politics, business and more.

CEL-SCI (NYSEAMERICAN:CVM) Stock Passes Below 50 Day Moving Average of $2.39

Shares of CEL-SCI Co. (NYSEAMERICAN:CVM – Free Report) passed below its fifty day moving average during trading on Thursday . The stock has a fifty day moving average of $2.39 and traded as low as $2.35. CEL-SCI shares last traded at $2.44, with a volume of 108,333 shares changing hands. Wall Street Analyst Weigh In […]
Swiss National Bank Renaissance Technologies Goldman Sachs Group Inc Company Profile Dimensional Fund Advisors Topco Ltd
Source: wkrb13.com

CEL-SCI (NYSEAMERICAN:CVM) Upgraded by StockNews.com to "Hold"

StockNews.com upgraded shares of CEL-SCI (NYSEAMERICAN:CVM – Free Report) from a sell rating to a hold rating in a research report released on Sunday. Separately, EF Hutton Acquisition Co. I reissued a buy rating and set a $10.00 price target on shares of CEL-SCI in a research note on Thursday, March 9th. CEL-SCI Price Performance […]
Geode Capital Management Renaissance Technologies A Davidson Vanguard Group Inc Ef Hutton Acquisition Co Millennium Management

CEL-SCI (NYSEAMERICAN:CVM) Upgraded to "Hold" at StockNews.com

StockNews.com upgraded shares of CEL-SCI (NYSEAMERICAN:CVM – Free Report) from a sell rating to a hold rating in a report released on Saturday morning. Separately, EF Hutton Acquisition Co. I reaffirmed a buy rating and set a $10.00 price objective on shares of CEL-SCI in a research report on Thursday, March 9th. CEL-SCI Price Performance […]
Goldman Sachs Group Inc Renaissance Technologies Swiss National Bank Ef Hutton Acquisition Co Dimensional Fund Advisors Company Profile

CEL-SCI (NYSEAMERICAN:CVM) Raised to "Hold" at StockNews.com

StockNews.com upgraded shares of CEL-SCI (NYSEAMERICAN:CVM – Free Report) from a sell rating to a hold rating in a research note released on Saturday. Separately, EF Hutton Acquisition Co. I restated a buy rating and issued a $10.00 price objective on shares of CEL-SCI in a research note on Thursday, March 9th. CEL-SCI Trading Up […]
Goldman Sachs Group Inc A Davidson Ef Hutton Acquisition Co Walleye Capital Da Davidson Renaissance Technologies

CEL-SCI (NYSEAMERICAN:CVM) Rating Lowered to Sell at StockNews.com

CEL-SCI (NYSEAMERICAN:CVM – Get Rating) was downgraded by analysts at StockNews.com from a “hold” rating to a “sell” rating in a research report issued on Sunday. Separately, EF Hutton Acquisition Co. I restated a “buy” rating and set a $10.00 price objective on shares of CEL-SCI in a research report on Thursday, March 9th. CEL-SCI […]
Investors Services Ef Hutton Acquisition Co Nations Financial Group Inc Company Profile Get Rating Sigma Investments

Stay Updated with Latest News

Get breaking news updates delivered to your inbox

Browse All News →

CEL-SCI (NYSEAMERICAN:CVM) Cut to Sell at StockNews.com

StockNews.com downgraded shares of CEL-SCI (NYSEAMERICAN:CVM – Get Rating) from a hold rating to a sell rating in a report released on Friday. Separately, EF Hutton Acquisition Co. I restated a buy rating and issued a $10.00 price objective on shares of CEL-SCI in a report on Thursday, March 9th. CEL-SCI Trading Up 2.7 % […]
Diamond Financial Cutter Co Brokerage Inc Threadgill Financial Company Profile Nations Financial Group Inc Ef Hutton Acquisition Co
Source: wkrb13.com

CEL-SCI (NYSE:CVM) Rating Lowered to Sell at StockNews.com

CEL-SCI (NYSE:CVM – Get Rating) was downgraded by analysts at StockNews.com from a “hold” rating to a “sell” rating in a report issued on Wednesday. CEL-SCI Stock Performance Shares of CEL-SCI stock traded down $0.03 on Wednesday, hitting $2.32. 134,300 shares of the company’s stock traded hands, compared to its average volume of 149,204. CEL-SCI […]
Get Rating Leukocyte Interleukin Cel Sci Nyse Cvm Stocknews Com

CEL-SCI (NYSE:CVM) Research Coverage Started at StockNews.com

StockNews.com started coverage on shares of CEL-SCI (NYSE:CVM – Get Rating) in a research note released on Thursday. The brokerage issued a hold rating on the stock. CEL-SCI Price Performance Shares of NYSE:CVM traded up $0.08 during midday trading on Thursday, reaching $2.64. The company had a trading volume of 5,553 shares, compared to its […]
Company Profile Get Rating Ligand Epitope Presentation System Cel Sci Nyse Cvm Initiated Coverage
Source: wkrb13.com

CEL-SCI (NYSEAMERICAN:CVM) Earns Hold Rating from Analysts at StockNews.com

StockNews.com started coverage on shares of CEL-SCI (NYSEAMERICAN:CVM – Get Rating) in a research note published on Thursday. The firm issued a hold rating on the stock. Separately, EF Hutton Acquisition Co. I reissued a buy rating and set a $10.00 target price on shares of CEL-SCI in a research report on Thursday, March 9th. […]
Ef Hutton Acquisition Co Investors Services Nations Financial Group Inc Company Profile Get Rating Sigma Investments

CEL-SCI Co. (NYSEAMERICAN:CVM) Short Interest Update

CEL-SCI Co. (NYSEAMERICAN:CVM – Get Rating) saw a significant increase in short interest in April. As of April 30th, there was short interest totalling 6,040,000 shares, an increase of 8.1% from the April 15th total of 5,590,000 shares. Based on an average daily volume of 187,400 shares, the days-to-cover ratio is currently 32.2 days. Analyst […]
Pricet Rowe Associates Inc Swiss National Bank Geode Capital Management Ef Hutton Acquisition Co Get Rating Capital Management

Explore More Categories

World News India News Business Technology Sports Entertainment Health Science